Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Adaptive Optics Imaging of Outer Retinal Diseases

NCT: NCT05355415 · RECRUITING

NCT IDNCT05355415
StatusRECRUITING
Start Date2021-08-27
Completion2028-09-30

Brief Summary

The objective of the study is to collect adaptive optics (AO) retinal images from human subjects with outer retinal diseases (diseases of the outer retina including photoreceptor, retinal pigment epithelium (RPE), basement membrane or choroidal pathologies) to develop new diagnostic methods, biomarkers, and clinical endpoints.

Frequently Asked Questions

What is Adaptive Optics Imaging of Outer Retinal Diseases?

Adaptive Optics Imaging of Outer Retinal Diseases is a clinical trial registered under NCT05355415. Current status: RECRUITING.

What is the status of NCT05355415?

The current status of NCT05355415 (Adaptive Optics Imaging of Outer Retinal Diseases) is: RECRUITING.

When did Adaptive Optics Imaging of Outer Retinal Diseases start?

Adaptive Optics Imaging of Outer Retinal Diseases started on 2021-08-27.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.